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A 33 year old woman with chronic myelogenous leuke-
mia presented with clinical symptoms and hemodynamic 
signs suggestive of pulmonary embolism. Initial angio-
graphic studies supported the diagnosis of a massive 
saddle pulmonary embolus, and an inferior vena cava 
filter was inserted. However, subsequent autopsy re-
The diagnosis of cor pulmonale secondary to massive pul-
monary embolism is usually based on the findings during 
cardiac catheterization of elevated right heart filling pres-
sures, reduced cardiac output and extensive intraluminal 
filling defects with greater than 50% obstruction of the pul-
monary circulation (I). However, in the patient with cancer, 
cor pulmonale due to pulmonary vascular obstruction may 
be a result of I) a large tumor mass occluding main pul-
monary artery branches, 2) microscopic tumor emboli oc-
cluding multiple small arteries, 3) carcinomatous lymphatic 
invasion, 4) external pulmonary vascular compression by a 
tumor, or 5) thromboembolism from the hypercoagulable 
state associated with the underlying malignancy (2-5). We 
studied a 33 year old woman on immunosuppressive therapy 
with chronic myelogenous leukemia in remission who had 
clinical, hemodynamic and angiographic findings of severe 
right heart failure that appeared to be caused by massive 
saddle pulmonary embolism. However, autopsy demon-
strated that these findings were due to unsuspected angioin-
vasive pulmonary aspergillosis with secondary in situ pul-
monary thrombosis. 
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vealed unsuspected angioinvasive pulmonary aspergil-
losis with secondary in situ thrombosis. The clinical 
features and diagnostic considerations in immunocom-
promised patients presenting with the clinical picture of 
pulmonary embolism are discussed. 
(J Am Coil CardioI1985;6:486-9) 
Case Report 
A 33 year old woman with chronic myelogenous leu-
kemia was admitted for evaluation of dyspnea and syncope. 
One year earlier, she had presented with leukocytosis, which 
was treated with intermittent busulfan. Eight months earlier, 
a lymphoid "blast crisis" stage was treated with a single 
course of vincristine, prednisone, hydroxyurea and adria-
mycin chemotherapy. Subsequent bone marrow examina-
tions revealed extensive myelofibrosis and hypocellularity 
without malignant cells. A right subclavian Hickman cath-
eter was inserted for chronic platelet and red blood cell 
transfusions. Several days before admission, she developed 
weakness and dyspnea and had a syncopal episode while 
walking. 
Clinical features. On admission, she was afebrile, and 
in respiratory distress. Blood pressure was 90/60 mm Hg 
without pulsus paradoxus, pulse was 140 beats/min and 
respirations were 44 breaths/min. The neck veins were dis-
tended. The lungs were clear. There was accentuation of 
the pulmonary valve closure sound and a parasternal im-
pulse. The liver was enlarged and tender. Mild right leg 
weakness was present. A right subclavian Hickman catheter 
was in place. The hematocrit was 28.8% and the white blood 
cell count was 1,400 mm3 with 35% neutrophils, 3% bands, 
50% lymphocytes, 6% monocytes, 5% basophils, 1% eo-
sinophils and no malignant cells. The platelet count was 
8,500. Arterial blood gases on room air were partial pressure 
of oxygen (Po2) 63 mm Hg, partial pressure of carbon diox-
ide (PC02) 23 mm Hg and pH 7.48. Chest roentgenogram 
showed a small chronic right mid-lung infiltrate unchanged 
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from prior studies. An electrocardiogram showed sinus 
tachycardia and a new "SIQ3T3" pattern (a pronounced S 
wave in lead I with an associated Q wave and inverted T 
wave in lead III). Computed tomographic studies of the 
pulmonary outflow tract with contrast medium showed no 
evidence of mediastinal adenopathy or masses. A techne-
tium-99 radionuclide lung scan suggested complete absence 
of perfusion to the right lung (Fig. I). 
Catheterization and treatment. Emergency cardiac 
catheterization was performed. The hemodynamic mea-
surements (Table 1) showed the presence of right ventricular 
failure with marked elevation of both right heart filling and 
pulmonary artery pressures. The pulmonary artery venous 
oxygen saturation was reduced, consistent with systemic 
hypoxemia and low cardiac output. Pulmonary angiography 
showed a large filling defect extending from the main pul-
monary artery into the right pulmonary artery with no flow 
to the right lung (Fig. 2). There was slow flow into the left 
pulmonary artery around the filling defect in the main pul-
monary artery with no evidence of peripheral left lung em-
boli. Superior vena cava venography showed no evidence 
of subclavian Hickman catheter thrombosis. 
Massive pulmonary saddle embolism was the presump-
tive diagnosis. Therapy with intravenous heparin, intrave-
nous streptokinase or surgical embolectomy was considered 
but rejected because of thrombocytopenia. A Greenfield 
inferior vena cava filter was placed with difficulty and it 
subsequently migrated into a renal vein. Broad spectrum 
Figure 1. The technetium-99 radionuclide lung perfusion scan in 
the anterior (A), posterior (P) and left lateral (L Lat) views shows 
complete absence of perfusion to the right lung, consistent with 
the presence of a massive pulmonary embolus obstructing flow to 
the right main pulmonary artery. 
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Table 1. Hemodynamic Data 
Heart rate (beats/min) 
Right atrial pressure (mean) 
(mm Hg) 
Pulmonary artery pressure (systolic/diastolic, mean) 
(mm Hg) 
Systemic arterial pressure (systolic/diastolic) 
(mm Hg) 
Pulmonary artery oxygen saturation (0/0) 
487 
138 
19 
72/27, 38 
82/60 
25 
antibiotic agents and high-dose parenteral corticosteroids 
were administered. Blood, urine and sputum cultures were 
negative for bacteria, fungi and acid-fast bacilli. The patient 
became progressively hypoxic, and died on the sixth hospital 
day. 
Autopsy findings (Fig. 3). A massive organizing, sad-
dle thrombus obstructed and conformed to the main (90% 
obstruction) and right (100% obstruction) pulmonary arter-
ies, with propagation into the secondary and tertiary branches 
of the right pulmonary artery. The thrombus was packed 
with myriad, septate, 5 to 10 mm thick, acutely branching 
filaments characteristic of Aspergillus Jumigatus. The right 
pulmonary artery showed evidence of vasculitis with hyphal 
invasion and vessel destruction. There were multiple small 
recent right lung infarcts. The heart was enlarged (390 g) 
with moderate right ventricular dilation and hypertrophy. 
An area of invasive aspergillosis was noted in the right upper 
pulmonary lobe (2 cm diameter) and most likely represented 
the primary focus of A. Jumigatus infection. In addition, 
multiple (left-sided) cerebrocortical lesions of invasive as-
Figure 2. Right anterior oblique view of contrast angiogram of 
the main pulmonary artery. The angiographic catheter tip lies im-
mediately inferior to a large filling defect (white arrows) in the 
main pulmonary artery. There was sluggish opacification of the 
left pulmonary artery (LPA) by contrast medium and virtually no 
opacification in the expected location of the right pulmonary artery 
(RPA). A subclavian Hickman catheter is present. 
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Figure 3. Aspergillus Jumigatus 
pulmonary artery thrombus. Left, 
Opened proximal main pulmo-
nary artery in situ (arrow) show-
ing complete occlusion at this 
level. Center, Fungal thrombus 
removed from pulmonary artery 
tree as a cast of main, left (L) and 
right (R) pulmonary arteries, 
Right, Septate, acutely branch-
ing hyphae characteristic of As-
pergillus (methenamine silver 
stain, x 375, reduced by 20%), 
pergillosis were noted, There was no systemic venous 
thrombosis, 
Discussion 
In this immunocompromised patient with leukemia, a 
diagnosis of subacute cor pulmonale secondary to massive 
pulmonary saddle embolism was based on hemodynamic 
and angiographic findings (6), Her progressive debilitation 
and immobility (7), Hickman catheter (8), repeated platelet 
transfusions (9) and underlying malignancy increased the 
risk for systemic venous thrombosis and subsequent pul-
monary embolism. However, autopsy revealed that pul-
monary vascular obstruction was caused by unsuspected 
angioinvasive pulmonary aspergillosis with secondary in 
situ thrombosis. 
Angioinvasive aspergillosis. In immunocompromised 
patients, a clinical and hemodynamic syndrome typical of 
massive pulmonary embolism may be caused by diseases 
other than systemic venous thromboembolism with differing 
management strategies and prognoses. Angioinvasive pul-
monary aspergillosis should be considered a cause of pul-
monary vascular obstruction in immunocompromised pa-
tients with leukemia, lymphoma or neutropenia after cytoxic 
chemotherapy (10). In several series of patients with acute 
leukemia, aspergillosis accounted for 12 to 55% of cases 
of invasive fungal infections, and roughly 40% of patients 
dying with leukemia had evidence of aspergillosis (11,12). 
As in our patient, the lung was the probable site of primary 
infection in more than 95% of the cases, with systemic 
dissemination occurring in 25% (13). The most common 
clinical presentation was unremitting fever with patchy 
bronchopneumonia often evident on roentgenogram but with 
almost invariably negative blood and cerebral spinal fluid 
cultures. In fact, the diagnosis was correctly established by 
sputum culture in only 12 to 34% of patients (13,14), un-
derscoring the need for tissue examination in patients at 
high risk for aspergillosis. 
Pathologic examination of lung tissue usually reveals 
bronchopneumonia with necrotizing bronchitis and invasion 
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of small blood vessels and pulmonary infarction due to 
invasion and occlusion of medium- or large-sized pUlmonary 
vessels (15). The angioinvasive properties of aspergillosis 
have contributed to the development of the superior vena 
cava syndrome (16), carotid arterial and cerebral occlusions 
(10), the Budd-Chiari syndrome and coronary artery throm-
bosis (14). The clinical, gross and histologic data in our 
patient suggested obstruction of the main pulmonary artery 
secondary to fungal invasion and injury of the underlying 
endothelium with secondary thrombus deposition. As our 
case illustrates, the diagnosis is often unsuspected ante-
mortem. This may contribute to the f~ct that overall mor-
tality is generally greater than 80% in patients with invasive 
aspergillosis although there are occasional reports of suc-
cessful therapy with amphoteracin B (17). 
Differential diagnosis. Other causes of pulmonary vas-
cular obstruction should also be considered in patients with 
dyspnea with underlying malignancy. Spontaneous tumor 
embolization that results in occlusion of the main pulmonary 
artery or large segmental branches and acute cor pulmonale 
is exceedingly rare (2,3,18). More frequently, acute cor 
pulmonale occurs during operative procedures from em-
bolization of tumors that tend to involve large systemic veins 
such as renal cell carcinoma (19,20), hepatoma (2), sarcoma 
(21) and choriocarcinoma (18). Tumor microembolization 
of small pulmonary vessels can lead to the gradual onset of 
dyspnea, hypoxemia, right ventricular hypertrophy and se-
vere pulmonary hypertension similar to the findings in our 
patient (20). This tumor embolization occurs in approxi-
mately 2% of all patients with solid malignant neoplasms 
in whom carcinoma of the breast (2-4,22), prostate (3), 
liver (2,3) and trophoblastic tissues (2) predominate. Chest 
roentgenogram, lung scan and angiographic studies are usu-
ally nondiagnostic and lung biopsy is often necessary to 
make the diagnosis. 
Lymphangitic carcinomatosis has been reported to produce 
a similar clinical picture of subacute cor pulmonale (4). 
Both peribronchial and perivascular pulmonary lymphatics 
become distended by the tumor, resulting in compression 
of the surrounding arterial system with associated arteriolar 
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thrombosis and endarteritis (23). Frequently, the generalized 
lymphatic involvement in such instances produces an "in-
terstitial infiltrate" pattern on chest roentgenograms. Car-
diac catheterization and pulmonary angiography show se-
vere pulmonary hypertension, poor perfusion of peripheral 
lung parenchyma and absence of proximal large intraluminal 
filling defects. A definitive diagnosis is usually made by 
biopsy or at autopsy. 
Conclusions. These observations suggest that exami-
nation of lung tissue to exclude the presence of angioin-
vasive aspergillosis or malignant cells within the microvas-
culature and lymphatics should be strongly considered in 
immunocompromised patients with clinical and hemody-
namic evidence of developing cor pulmonale before car-
diovascular collapse. Although tissue biopsy must be un-
dertaken with caution in patients with neutropenia and 
thrombocytopenia, the risks of this procedure may be out-
weighed by the morbidity of inappropriate administration 
of streptokinase, heparin or vena caval filter placement in 
patients with the incorrect diagnosis of systemic venous 
thromboembolism, and by the possible recovery of occa-
sional patients with the use of anticancer or antifungal 
chemotherapy. 
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